An NF-κB pathway inhibitor (QNZ) significantly inhibited the phosphorylation of P65 (Fig. S6b), the expression of the CSC marker (Fig. S6c), and the ability of tumor sphere formation (Fig. S6d) and metastasis (Fig. S6e), as demonstrated by WB. Here, NFKB1 is linked to neoplasm.